Moderate Established

描述

Diltiazem significantly increases digoxin plasma levels through P-gp inhibition and may additionally slow AV nodal conduction, exacerbating bradycardia or heart block.

机制

Diltiazem inhibits P-glycoprotein–mediated renal and biliary excretion of digoxin; it also has intrinsic negative chronotropic and dromotropic effects on the AV node, adding to digoxin's vagotonic actions.

临床意义

Digoxin AUC increases by ~20–30%; symptomatic bradycardia, AV block, and digoxin toxicity have been reported.

处理措施

Monitor heart rate and digoxin levels; reduce digoxin dose by ~25% when initiating diltiazem; avoid combination in patients with pre-existing conduction disease.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.